• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SMARCA4缺陷型胸段肉瘤:一例病例报告及文献综述

SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.

作者信息

Stewart Brian D, Kaye Frederic, Machuca Tiago, Mehta Hiren J, Mohammed Tan-Lucien, Newsom Kimberly J, Starostik Petr

机构信息

University of Florida, Gainesville, FL, USA.

出版信息

Int J Surg Pathol. 2020 Feb;28(1):102-108. doi: 10.1177/1066896919865944. Epub 2019 Aug 5.

DOI:10.1177/1066896919865944
PMID:31382829
Abstract

SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently described entity with a poor prognosis that is defined by certain genetic alterations in the BAF chromatin remodeling complex, specifically and . We present a case of a SMARCA4-DTS in a 59 year-old male with a heavy smoking history who was found to have an unexpected right upper lobe lung mass on routine chest radiograph after a visit to his primary care physician. This led to a biopsy with a diagnosis of poorly differentiated carcinoma at an outside institution. The patient was subsequently seen at our facility for surgical intervention. The right upper lobectomy contained a 7.2-cm poorly differentiated malignancy with slightly discohesive cells arranged in sheets and nests, abundant geographic necrosis, and with many areas showing rhabdoid morphology. The tumor was focally reactive for CK7, AE1/3, Cam5.2, and SALL4 and showed scattered reactivity for CD34 and SOX2. There was complete loss of reactivity for both SMARCA4 and SMARCA2. The histology and immunophenotype were all consistent with the diagnosis of a SMARCA4-DTS. Next-generation sequencing showed a frameshift mutation in the gene and no abnormality with the gene. Interestingly, this tumor was confined to the pulmonary parenchyma with no invasion of the visceral pleura nor the mediastinum and with no clinically apparent metastases at the time of presentation. This case is presented to add to the cohort of cases described to date and to discuss the immunohistochemical and molecular findings with regard to .

摘要

SMARCA4缺陷型胸肉瘤(SMARCA4-DTS)是一种最近被描述的预后不良的实体瘤,由BAF染色质重塑复合体中的某些基因改变所定义,具体为 和 。我们报告一例59岁有重度吸烟史的男性SMARCA4-DTS病例,该患者在就诊于初级保健医生后,常规胸部X线检查发现右上叶肺部有意外肿块。这导致在外院进行活检,诊断为低分化癌。患者随后到我们机构接受手术干预。右上叶切除标本中含有一个7.2厘米的低分化恶性肿瘤,细胞轻度松散,呈片状和巢状排列,有大量地图状坏死,许多区域显示横纹肌样形态。肿瘤对CK7、AE1/3、Cam5.2和SALL4呈局灶性反应,对CD34和SOX2呈散在反应。SMARCA4和SMARCA2均完全丧失反应性。组织学和免疫表型均符合SMARCA4-DTS的诊断。二代测序显示 基因存在移码突变, 基因无异常。有趣的是,该肿瘤局限于肺实质,未侵犯脏层胸膜和纵隔,就诊时无临床明显转移。本文报告此病例以增加迄今所描述的病例队列,并讨论关于 的免疫组化和分子学发现。

相似文献

1
SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.SMARCA4缺陷型胸段肉瘤:一例病例报告及文献综述
Int J Surg Pathol. 2020 Feb;28(1):102-108. doi: 10.1177/1066896919865944. Epub 2019 Aug 5.
2
Cytopathological Features of -Deficient Thoracic Sarcoma: Report of 2 Cases and Review of the Literature.- 缺乏(此处原文“-Deficient”表述不完整,推测可能是某种特定因子缺乏)的胸段肉瘤的细胞病理学特征:2例报告及文献复习
Int J Surg Pathol. 2020 Feb;28(1):109-114. doi: 10.1177/1066896919870866. Epub 2019 Aug 25.
3
SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.SMARCA4 缺陷性胸肉瘤:30 例临床病理研究,重点在于其分类学和鉴别诊断。
Am J Surg Pathol. 2019 Apr;43(4):455-465. doi: 10.1097/PAS.0000000000001188.
4
Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.SMARCA4 缺陷性胸肉瘤的临床病理和分子特征,并与潜在相关实体进行比较。
Mod Pathol. 2017 Jun;30(6):797-809. doi: 10.1038/modpathol.2017.11. Epub 2017 Mar 3.
5
Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.SMARCA4缺陷型胸壁肉瘤的细胞学特征:一例报告并与其他SWI/SNF复合物缺陷型肿瘤的比较
Acta Cytol. 2018;62(5-6):456-462. doi: 10.1159/000493335. Epub 2018 Oct 4.
6
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.SMARCA4 缺陷性胸壁肉瘤:一种具有未分化横纹肌样形态和侵袭性行为的独特临床病理实体。
Mod Pathol. 2017 Oct;30(10):1422-1432. doi: 10.1038/modpathol.2017.61. Epub 2017 Jun 23.
7
SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.非小细胞肺癌中SMARCA4和SMARCA2缺陷:316例连续标本的免疫组织化学研究
Ann Diagn Pathol. 2017 Feb;26:47-51. doi: 10.1016/j.anndiagpath.2016.10.006. Epub 2016 Oct 20.
8
SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1/CK7/HepPar-1 immunophenotype.SMARCA4缺陷型肺腺癌:一种具有一致的TTF1/CK7/HepPar-1免疫表型的新型侵袭性肿瘤的临床病理、免疫组化和分子特征
Virchows Arch. 2017 Nov;471(5):599-609. doi: 10.1007/s00428-017-2148-5. Epub 2017 May 30.
9
Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.伴有神经节神经瘤和内生软骨瘤的胸椎SMARCA4缺陷未分化肿瘤:对SLC7A11和ARID1A表达的影响:一例报告
Diagn Pathol. 2022 Feb 12;17(1):29. doi: 10.1186/s13000-022-01205-8.
10
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.SWI/SNF复合物ATP酶SMARCA4/BRG1和SMARCA2/BRM的双重缺失对高钙血症型卵巢小细胞癌具有高度敏感性和特异性。
J Pathol. 2016 Feb;238(3):389-400. doi: 10.1002/path.4633. Epub 2015 Dec 21.

引用本文的文献

1
Updating the genomic and clinicopathologic features of thoracic SMARCA4-deficient undifferentiated tumor: a mini-series including a long-term survivor.更新胸段SMARCA4缺陷型未分化肿瘤的基因组和临床病理特征:一个包括长期存活者的小型系列研究。
Front Oncol. 2025 Aug 20;15:1601443. doi: 10.3389/fonc.2025.1601443. eCollection 2025.
2
Long-term survival of a SMARCA4-deficient undifferentiated thoracic tumor with brain metastasis successfully treated with multimodal treatment: a case report and literature review.经多模式治疗成功治愈的伴有脑转移的SMARCA4缺陷型未分化胸腺瘤的长期生存:病例报告及文献综述
J Cancer Res Clin Oncol. 2025 Aug 23;151(8):234. doi: 10.1007/s00432-025-06284-w.
3
Concurrent SMARCA4-deficient and poorly differentiated adenocarcinomas in separate lung lobes: a case report and literature review.
不同肺叶同时存在SMARCA4缺陷型和低分化腺癌:一例报告及文献综述
World J Surg Oncol. 2025 May 22;23(1):198. doi: 10.1186/s12957-025-03839-6.
4
Successful Diagnosis of a SMARCA4-Deficient Undifferentiated Tumor via Endobronchial Ultrasound-Guided Fine Needle Aspiration and Endobronchial Biopsies.通过支气管内超声引导下细针穿刺活检和支气管活检成功诊断SMARCA4缺陷型未分化肿瘤
Cureus. 2024 Dec 30;16(12):e76649. doi: 10.7759/cureus.76649. eCollection 2024 Dec.
5
A retrospective study of the efficacy and safety of immune checkpoint inhibitors combined with chemotherapy for the treatment of SMARCA4-deficient thoracic tumors.免疫检查点抑制剂联合化疗治疗SMARCA4缺陷型胸部肿瘤的疗效和安全性的回顾性研究。
Transl Lung Cancer Res. 2024 Dec 31;13(12):3460-3472. doi: 10.21037/tlcr-24-691. Epub 2024 Dec 27.
6
The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation.打开 SMARCA4 缺陷未分化胸腺瘤神秘盒子的金钥匙:聚焦免疫治疗、肿瘤微环境和表观遗传调控。
Cancer Gene Ther. 2024 May;31(5):687-697. doi: 10.1038/s41417-024-00732-4. Epub 2024 Feb 13.
7
Under the Microscope: A Case Report of Thoracic SMARCA4-Deficient Undifferentiated Tumor with Review of the Literature.显微镜下:伴有文献复习的胸 SMARCA4 缺陷未分化肿瘤病例报告。
Turk Patoloji Derg. 2024;40(2):128-133. doi: 10.5146/tjpath.2023.12965.
8
Thoracic SMARCA4-deficient undifferentiated tumor.胸段SMARCA4缺陷型未分化肿瘤。
Discov Oncol. 2023 Apr 28;14(1):51. doi: 10.1007/s12672-023-00639-w.
9
Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure.病例报告:1例伴有呼吸衰竭的胸部SMARCA4缺陷型未分化肿瘤对免疫疗法的快速反应。
Front Oncol. 2022 Nov 1;12:1020875. doi: 10.3389/fonc.2022.1020875. eCollection 2022.
10
A dramatic course after the resection of an SMARCA4-deficient undifferentiated tumour.SMARCA4缺陷型未分化肿瘤切除术后的戏剧性病程。
Respirol Case Rep. 2022 Jul 6;10(8):e01001. doi: 10.1002/rcr2.1001. eCollection 2022 Aug.